Catalyst Wire Dossier Catalyst Wire Dossier

ANZUPGO

delgocitinib · LEO Pharma, Inc
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ANZUPGO, covering 2025-07-23 to 2026-07-17. Get the full timeline:

Most recent: EMA Authorised: Anzupgo (Delgocitinib) — LEO Pharma A/S

See pricing